1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Diclofenac Sodium Market
4. Executive Summary
5. Manufacturing
Diclofenac Sodium
5.1.
Raw Material
5.2.
Machinery
5.3.
Manufacturing Methods
5.4.
Contact Details of Machinery & Raw Material Suppliers
6. Pharmacodynamic
Overview of Diclofenac Sodium
6.1.
Mechanism of Action
6.2.
Absorption
6.3.
Volume of Distribution
6.4.
Protein Binding
6.5.
Metabolism
6.6.
Route of Elimination
6.7.
Half-Life
6.8.
Clearance
6.9.
Toxicity
7. India Diclofenac
Sodium Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Product Type
(Prescription v/s OTC)
7.2.2. By Form (Tablet,
Injection, Gel, Others)
7.2.3. By Application
(Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis,
Migraine, Pain and Others)
7.2.4. By Route of
Administration (Oral, Intravenous, Topical, Others)
7.2.5. By Source (In-house
v/s Contract Manufacturing Organizations)
7.2.6. By Distribution
Channel (Online v/s Offline)
7.2.7. By End User (Adult
v/s Paediatric)
7.2.8. By Region (North,
East, South, West)
7.2.9. By Company
7.3.
Product Market Map
8.
Market Dynamics
8.1.
Drivers/Opportunities
8.2.
Challenges/Restraints
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
10.1.
Custom Duty & Taxes
10.2.
Government Subsidy & Benefits
10.3.
Relevant Policies & Regulations (GMP, USFDA, WHO
Certifications)
11.
Import & Export Analysis
12.
Pricing Analysis
13.
India Economic Profile
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Novartis India Ltd.
14.1.1.1. Company Brief
14.1.1.2. Production Plants
& Capacity (If Available)
14.1.1.3. Financials (If
Available)
14.1.1.4. Captive Consumption
Vs Merchant Sale
14.1.1.5. Current & Future
Plans
14.1.2. Hetero Drugs Ltd.
14.1.3. Auro Laboratories
Ltd.
14.1.4. Aarti Drugs Ltd.
14.1.5. J B Chemicals and
Pharmaceuticals Ltd.
14.1.6. Novartis India Ltd.
14.1.7. Emkay Pharma Pvt.
Ltd.
14.1.8. Bestochem Formulations
(India) Limited
14.1.9. Salvavidas
Pharmaceutical Pvt. Ltd.
14.1.10.
Wellona Pharma Pvt. Ltd.
15.
Strategic Recommendations
About Us &
Disclaimer